Institutional Fund
B Group, Inc.
Dallas, TXCIK 20434765 filings on record
Portfolio Value
$134.89M
Q1 2026
Holdings
20
Reported positions
New Buys
5
Opened this quarter
QoQ Change
-0.0%
from $134.95M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Adma Biologics Inc21.4%
- Palisade Bio Inc14.8%
- Praxis Precision Medicines I7.9%
- Cellectis S A7.7%
- Zai Lab Ltd6.3%
- Taysha Gene Therapies Inc6.0%
- Other35.9%
Portfolio Holdings
20 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Adma Biologics Inc | 3.21M | $28.90M | 21.4% | +750.0K | Added |
| 2 | Palisade Bio Inc | 11.41M | $19.97M | 14.8% | +6.91M | Added |
| 3 | Praxis Precision Medicines I | 33.2K | $10.71M | 7.9% | 0 | Held |
| 4 | Cellectis S A | 3.28M | $10.40M | 7.7% | 0 | Held |
| 5 | Zai Lab Ltd | 450.6K | $8.48M | 6.3% | +50.6K | Added |
| 6 | Taysha Gene Therapies Inc | 1.80M | $8.05M | 6.0% | 0 | Held |
| 7 | Nrx Pharmaceuticals Inc | 3.00M | $6.39M | 4.7% | +3.00M | New |
| 8 | Structure Therapeutics Inc | 127.5K | $6.15M | 4.6% | +37.5K | Added |
| 9 | Iovance Biotherapeutics Inc | 1.50M | $5.26M | 3.9% | 0 | Held |
| 10 | Spyre Therapeutics Inc | 100.0K | $5.04M | 3.7% | 0 | Held |
10 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio